TransCode Therapeutics, Inc.

NASDAQ: RNAZ · Healthcare · Biotechnology

PublicHQ Boston, MA · SuffolkCIK 0001829635Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 57DQ —GM —SS 29

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, return on assets · ↓ Piotroski F, listing tenure

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$34.7M

Employees

Market cap

$8.2M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$34.7M-$34.7M2025

Operating income-$28.0M-$28.0M2025

Total assets$162.4M$162.4M2025

Liabilities$10.5M$10.5M2025

Equity$10.3M$10.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

TransCode Therapeutics, Inc. earned -$34.7M in FY2025 net income.

Peers · Healthcare

Bullfrog AI Holdings, Inc. Common Stock30D Synlogic, Inc.45D VistaGen Therapeutics, Inc.46D Leveljump Healthcare Corp.——

Neighbors

Suffolk →

Vertex Pharmaceuticals Incorporated$12.0B88A American Tower Corporation$935.9M75B+State Street Corporation$13.9B67B NSTAR Electric Company——Toast, Inc.$6.2B67B PTC Inc.$2.7B84B+

Key facts

CEOPhilippe Calais

SectorHealthcare

IndustryBiotechnology

HeadquartersBoston, MA

ExchangeNASDAQ: RNAZ

Employees7

IPO date2021-07-08

Latest filings

8-K2026-07-02 8-K2026-06-18 8-K2026-06-03 DEF 14A2026-06-02 8-K2026-06-01 8-K2026-05-22 10-Q2026-05-15 10-K2026-04-15

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.